Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Perhaps PTSC didn't "have to", but......opty...

Sep 25, 2011 12:04PM

I'll admit that the wording of the agreement is not always easy to follow, but I think this exercise is worth the effort for those reading the thread.

Why is it assumed that the commercialization agreement would not cover protection of the patents? Wouldn't somebody need to be authorized to do whatever is necessary with respect to USPTO? One could argue that the USPTO challenges are directly related to litigation, since they are. In any case I believe such is covered in 7.2 regarding maintenance of the patents.

Back to the wording of 7.6. You are arguing that "including, without limitation" is limited because defending the patents at the USPTO was not contemplated in the agreement. If maintaining the patents in 7.2 includes defending them at the USPTO, then such is contemplated.

But even if you disagreed with what 7.2 meant, I think reexams are simply a subset of litigation. IMO.

Opty

7
Sep 28, 2011 05:19PM
Share
New Message
Please login to post a reply